Overview
MYTIGATE provides a GDP compliance platform for pharmaceutical distributors, helping them follow their country’s Good Distribution Practice guidelines. It supports documentation, audits, and records management across the supply chain, including temperature-controlled logistics, supplier quality, and training, to keep activities and records compliant. The product guides users through checklists, automates document control, and continuously monitors processes to produce ready-to-audit reports. It differentiates from competitors by offering country-specific GDP workflows and reporting that align with local regulations, aiming to help pharma companies meet regulatory requirements and pass inspections.
Work here?Claim your company
Simplify's Take
What believers are saying
- Mytigate's 2026 Pharma.Aero role boosts access to global shippers and carriers.
- Its validated risk scoring directly addresses GDP, FDA, and IATA compliance pressure.
- The DSV-linked ecosystem can accelerate pilots and shorten procurement cycles.
What critics are saying
- Qualifyze and other audit platforms commoditize Mytigate's verification layer by 2027.
- Customer adoption depends on pharma's willingness to share sensitive lane performance data.
- A failed enterprise sales cycle leaves Mytigate stuck as a niche compliance tool.
What makes Mytigate unique
- Validated CFR21 Part 11 platform anchors Mytigate in regulated pharma logistics.
- It benchmarks transport partners using lane risk, temperature data, and compliance documentation.
- Pharma.Aero associate partnership with DSV expands ecosystem credibility in 2026.
Help us improve and share your feedback! Did you find this helpful?